<DOC>
	<DOCNO>NCT02480647</DOCNO>
	<brief_summary>Randomized clinical trial use levonorgestrel release intrauterine system . Objectives : To evaluate compare efficacy of- levonorgestrel release intrauterine system l ( LNG-IUS ) relation subdermal implant release etonogestrel ( ENG ) control chronic pelvic pain / dysmenorrhea woman endometriosis .</brief_summary>
	<brief_title>Clinical Trial Use Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant Endometriosis</brief_title>
	<detailed_description>Randomized clinical trial use levonorgestrel release intrauterine system . Objectives : To evaluate compare efficacy of- levonorgestrel release intrauterine system ( LNG-IUS ) relation subdermal implant release etonogestrel ( ENG ) control chronic pelvic pain / dysmenorrhea woman endometriosis . Methods : Will assess 100 woman , age 18-45 year , diagnosis endometriosis confirm laparoscopy laparotomy present chronic pelvic pain / dysmenorrhea . The study experimental , randomize , ( 50 woman allocate LNG-IUS 50 woman use implant subdermal ENG ) . Women invite participate study day Family Planning Clinic pelvic pain complaint / dysmenorrhea confirm diagnosis endometriosis search insert LNG-IUS . That day invite allocated lottery ( system computer generate randomization ; opaque seal envelope ) , group use LNG-IUS subdermal implant ENG . At inclusion study hold insertion LNG-IUS ENG implant day pain evaluate visual analogue scale ( VAS ) pain applied evaluation questionnaire endometriosis . It calendar record deliver daily bleed EVA daily assessment pain . Women return 30 day ( ± 3 day ) pain registration evaluate EVA collect bleed deliver new calendar next 30 day . The end study It expect 180 day post-insertion LNG-IUS implant , latter evaluation , apply questionnaire . Cancer antigen 125 ( CA-125 ) evaluate baseline last follow-up ( +/- 180 day ) . Inclusion criterion : - Women age 18 45 - Absence pregnancy - Patients chronic pelvic pain / dysmenorrhea pain score ≥ 4 EVA pain surgical histopathological diagnosis endometriosis 14 last three month two year , accord current classification American Society Reproductive Medicine - Accept participate sign consent form clarify .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Women age 18 45 Absence pregnancy Patients chronic pelvic pain / dysmenorrhea pain score ≥ 4 EVA pain surgical histopathological diagnosis endometriosis 14 last three month two year , accord current classification American Society Reproductive Medicine Accept participate sign consent form clarify Exclusion criterion : Current wish get pregnant I want use LNGIUS treatment Contraindication use LNGIUS : Current pelvic inflammatory disease appellant ; infection lower genital tract ; infect abortion last 3 month ; purulent cervicitis ; uterine cervical malignancy ; bleed abnormal uterine undiagnosed ; congenital uterine anomaly acquire condition associate increased susceptibility infection ; acute liver disease liver tumor ; hypersensitivity LNG . Contraindications use ENG implant : pregnancy suspect pregnancy ; Active venous thromboembolic disorder ; presence history liver disease serious liver function value return normal ; progestogen dependent tumor ; abnormal bleeding undiagnosed ; hypersensitivity component implante . Abusive use alcohol / illicit drug .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>